RE:RE:RE:Newsthesheet wrote: sounds like good news to me,(and the patients).
more patience is required on the sell on the news
When I read it what stood out as a possible negative was the response in the intravenous group. 5 out of 18 with an "objective response" sounded a little low (and vague). But honestly I dont know whether this is above or below expectations ATM. The intratumoral stuff is exciting and shows the potential for the drug but the intravenous dosing needs to work for this to be a plausible drug I would think. Clearly they are considering going with higher doses now that the first dose negative reaction is better understood.